US Map / North Dakota
State ND

Clinical Trials in North Dakota

Recruiting clinical trials with at least one study location in North Dakota. Data updated daily from ClinicalTrials.gov.

Total Trials
39
Recruiting Now
39
← Back to US Map
Top Conditions in North Dakota
Lung Non-Small Cell Carcinoma (2)Stage II Lung Cancer AJCC v8 (2)Stage IIIA Lung Cancer AJCC v8 (2)Stage IIIB Lung Cancer AJCC v8 (2)Amblyopia (2)Anatomic Stage IV Breast Cancer AJCC v8 (2)Stage IV Nasopharyngeal Carcinoma AJCC v8 (2)Breast Cancer (2)Anatomic Stage I Breast Cancer AJCC v8 (1)Anatomic Stage II Breast Cancer AJCC v8 (1)Anatomic Stage IIIA Breast Cancer AJCC v8 (1)Anatomic Stage IIIB Breast Cancer AJCC v8 (1)

Frequently Asked Questions — Clinical Trials in North Dakota

How many clinical trials are currently recruiting in North Dakota?
ClinicalMetric currently tracks 39 actively recruiting clinical trials with at least one location in North Dakota. The total number of registered studies—including active but not currently enrolling trials—is 39. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in North Dakota?
North Dakota hosts clinical trials across a broad range of medical conditions, including Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8, Stage IIIA Lung Cancer AJCC v8, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout North Dakota serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in North Dakota?
To join a clinical trial in North Dakota, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in North Dakota maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in North Dakota

NCT04566328 Phase 3
Recruiting
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Mu...
Condition
Plasma Cell Myeloma
Enrollment
1,450 pts
Location
United States, Puerto Rico
Sponsor
ECOG-ACRIN Cancer Research Gro
View Trial →
NCT07064473 Phase 3
Recruiting
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empag...
Condition
Diabetes Mellitus, Type 2
Enrollment
11,800 pts
Location
United States, Argentina, Australia
Sponsor
Boehringer Ingelheim
View Trial →
NCT06846281 Phase 3
Recruiting
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Particip...
Condition
Relapsing Multiple Sclerosis
Enrollment
360 pts
Location
United States, Argentina, Australia
Sponsor
Novartis Pharmaceuticals
View Trial →
NCT06395103 Phase 1, Phase 2
Recruiting
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants Wit...
Condition
B-cell Acute Lymphoblastic Leukemia
Enrollment
90 pts
Location
United States, Australia, Belgium
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT06064097 Phase 2
Recruiting
A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopha...
Condition
Stage II Nasopharyngeal Carcinoma AJCC v8
Enrollment
50 pts
Location
United States, Canada, New Zealand
Sponsor
National Cancer Institute (NCI
View Trial →
NCT03488693 Phase 3
Recruiting
Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer
Condition
Breast Cancer
Enrollment
2,140 pts
Location
United States, Canada
Sponsor
Canadian Cancer Trials Group
View Trial →
NCT05904080 Phase 2
Recruiting
Testing Nivolumab and Ipilimumab Immunotherapy With or Without the Targeted Drug...
Condition
Metastatic Nasopharyngeal Carcinoma
Enrollment
50 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT07184996 Phase 3
Recruiting
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Partic...
Condition
Ulcerative Colitis
Enrollment
980 pts
Location
United States, Bulgaria, Canada
Sponsor
Sanofi
View Trial →
NCT07252739 Phase 2
Recruiting
KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants...
Condition
Malignant Neoplasm
Enrollment
130 pts
Location
United States, China, Finland
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT05263206 Phase 3
Recruiting
Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Partici...
Condition
Pruritus
Enrollment
284 pts
Location
United States, Argentina, Canada
Sponsor
Sanofi
View Trial →
NCT04242095 N/A
Recruiting
Collection of Research Data and Samples From Patients Who Experience Immunothera...
Condition
Malignancy
Enrollment
240 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
View Trial →
NCT05454189 N/A
Recruiting
Safety of Extending The Routine Flushing Of Implanted Port Devices From 4 Weeks ...
Condition
Maintenance of Implanted Port Devices
Enrollment
400 pts
Location
United States
Sponsor
Essentia Health
View Trial →
NCT03452774 N/A
Recruiting
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matc...
Condition
Cancer, Metastatic
Enrollment
50,000 pts
Location
United States, Puerto Rico
Sponsor
Massive Bio, Inc.
View Trial →
NCT06203600 Phase 2, Phase 3
Recruiting
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophage...
Condition
Advanced Esophageal Adenocarcinoma
Enrollment
224 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
Page 2 of 2 — 39 trials total
← Prev
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology